Pulmonary and Cardiorenal Cyclooxygenase-1 (COX-1),  -2 (COX-2), and Microsomal Prostaglandin E Synthase-1 (mPGES-1) and -2 (mPGES-2) Expression in  a Hypertension Model

Radi, Zaher A.; Ostroski, Robert

doi:https://doi.org/10.1155/2007/85091

Mediators of Inflammation

On this page

Abstract References Copyright Related Articles

Research Article | Open Access

Volume 2007 | Article ID 085091 | https://doi.org/10.1155/2007/85091

Pulmonary and Cardiorenal Cyclooxygenase-1 (COX-1), -2 (COX-2), and Microsomal Prostaglandin E Synthase-1 (mPGES-1) and -2 (mPGES-2) Expression in a Hypertension Model

Zaher A. Radi¹and Robert Ostroski²

Received01 Feb 2007

Accepted16 Mar 2007

Published17 May 2007

Abstract

Hypertensive mice that express the human renin and angiotensinogen genes are used as a model for human hypertension because they develop hypertension secondary to increased renin-angiotensin system activity. Our study investigated the cellular localization and distribution of COX-1, COX-2, mPGES-1, and mPGES-2 in organ tissues from a mouse model of human hypertension. Male (n=15) and female (n=15) double transgenic mice (h-Ang 204/1 h-Ren 9) were used in the study. Lung, kidney, and heart tissues were obtained from mice at necropsy and fixed in 10% neutral buffered formalin followed by embedding in paraffin wax. Cut sections were stained immunohistochemically with antibodies to COX-1, COX-2, mPGES-1, and mPGES-2 and analyzed by light microscopy. Renal expression of COX-1 was the highest in the distal convoluted tubules, cortical collecting ducts, and medullary collecting ducts; while proximal convoluted tubules lacked COX-1 expression. Bronchial and bronchiolar epithelial cells, alveolar macrophages, and cardiac vascular endothelial cells also had strong COX-1 expression, with other renal, pulmonary, or cardiac microanatomic locations having mild-to-moderate expression. mPGES-2 expression was strong in the bronchial and bronchiolar epithelial cells, mild to moderate in various renal microanatomic locations, and absent in cardiac tissues. COX-2 expression was strong in the proximal and distal convoluted tubules, alveolar macrophages, and bronchial and bronchiolar epithelial cells. Marked mPGES-1 was present only in bronchial and bronchiolar epithelial cells; while mild-to-moderate expression was present in other pulmonary, renal, or cardiac microanatomic locations. Expression of these molecules was similar between males and females. Our work suggests that in hypertensive mice, there are (a) significant microanatomic variations in the pulmonary, renal, and cardiac distribution and cellular localization of COX-1, COX-2, mPGES-1, and mPGES-2, and (b) no differences in expression between genders.

References

N. J. Brown, “Eplerenone: cardiovascular protection,” Circulation, vol. 107, no. 19, pp. 2512–2518, 2003.
View at: Publisher Site | Google Scholar
M. W. Thompson, S. B. Smith, and C. D. Sigmund, “Regulation of human renin mRNA expression and protein release in transgenic mice,” Hypertension, vol. 28, no. 2, pp. 290–296, 1996.
View at: Google Scholar
J. L. Lavoie and C. D. Sigmund, “Minireview: overview of the renin-angiotensin system—an endocrine and paracrine system,” Endocrinology, vol. 144, no. 6, pp. 2179–2183, 2003.
View at: Publisher Site | Google Scholar
M. A. E. Lee, M. Bohm, M. Paul, M. Bader, U. Ganten, and D. Ganten, “Physiological characterization of the hypertensive transgenic rat TGR(mREN2)27,” American Journal of Physiology—Endocrinology and Metabolism, vol. 270, no. 6, pp. E919–E929, 1996.
View at: Google Scholar
T. Shimokama, S. Haraoka, H. Horiguchi, F. Sugiyama, K. Murakami, and T. Watanabe, “The Tsukuba hypertensive mouse (transgenic mouse carrying human genes for both renin and angiotensinogen) as a model of human malignant hypertension: development of lesions and morphometric analysis,” Virchows Archiv, vol. 432, no. 2, pp. 169–175, 1998.
View at: Publisher Site | Google Scholar
F. Pieruzzi, Z. A. Abassi, and H. R. Keiser, “Expression of renin-angiotensin system components in the heart, kidneys, and lungs of rats with experimental heart failure,” Circulation, vol. 92, no. 10, pp. 3105–3112, 1995.
View at: Google Scholar
A. Fukamizu, K. Sugimura, and E. Takimoto et al., “Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes,” Journal of Biological Chemistry, vol. 268, no. 16, pp. 11617–11621, 1993.
View at: Google Scholar
T. Kai, S. Shimada, A. Kurooka, T. Takenaka, and K. Ishikawa, “Tissue angiotensin II concentration in the heart and kidneys in transgenic Tsukuba hypertensive mice,” Blood Pressure, vol. 7, no. 1, pp. 61–63, 1998.
View at: Google Scholar
R. C. Harris, “Interactions between COX-2 and the renin-angiotensin system in the kidney,” Acta Physiologica Scandinavica, vol. 177, no. 4, pp. 423–427, 2003.
View at: Publisher Site | Google Scholar
R. C. Harris and M. D. Breyer, “Physiological regulation of cyclooxygenase-2 in the kidney,” American Journal of Physiology—Renal Physiology, vol. 281, no. 1, pp. F1–F11, 2001.
View at: Google Scholar
A. Schneider, Y. Zhang, and M. Zhang et al., “Membrane-associated PGE synthase-1 (mPGES-1) is coexpressed with both COX-1 and COX-2 in the kidney,” Kidney International, vol. 65, no. 4, pp. 1205–1213, 2004.
View at: Publisher Site | Google Scholar
R. C. Harris, M.-Z. Zhang, and H.-F. Cheng, “Cyclooxygenase-2 and the renal renin-angiotensin system,” Acta Physiologica Scandinavica, vol. 181, no. 4, pp. 543–547, 2004.
View at: Publisher Site | Google Scholar
A. Yabuki, M. Matsumoto, R. Kamimura, K. Taniguchi, and S. Suzuki, “Renin, cyclooxygenase-2 and neuronal nitric oxide synthase in the kidneys of transgenic Tsukuba hypertensive mouse,” Experimental Animals, vol. 53, no. 4, pp. 387–390, 2004.
View at: Publisher Site | Google Scholar
T. Kai, H. Kino, and K. Ishikawa, “Role of the renin-angiotensin system in cardiac hypertrophy and renal glomerular sclerosis in transgenic hypertensive mice carrying both human renin and angiotensinogen genes,” Hypertension Research, vol. 21, no. 1, pp. 39–46, 1998.
View at: Google Scholar
J. Blanco-Rivero, V. Cachofeiro, and V. Lahera et al., “Participation of prostacyclin in endothelial dysfunction induced by aldosterone in normotensive and hypertensive rats,” Hypertension, vol. 46, no. 1, pp. 107–112, 2005.
View at: Publisher Site | Google Scholar
J. L. Stock, K. Shinjo, and J. Burkhardt et al., “The prostaglandin $E_{2}$ EP1 receptor mediates pain perception and regulates blood pressure,” Journal of Clinical Investigation, vol. 107, no. 3, pp. 325–331, 2001.
View at: Google Scholar
E. A. Millar, R. M. Angus, G. Hulks, J. J. Morton, J. M. C. Connell, and N. C. Thomson, “Activity of the renin-angiotensin system in acute severe asthma and the effect of angiotensin II on lung function,” Thorax, vol. 49, no. 5, pp. 492–495, 1994.
View at: Google Scholar
M. D. Breyer, H. R. Jacobson, and R. M. Breyer, “Functional and molecular aspects of renal prostaglandin receptors,” Journal of the American Society of Nephrology, vol. 7, no. 1, pp. 8–17, 1996.
View at: Google Scholar
W. L. Smith, R. M. Garavito, and D. L. DeWitt, “Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2,” Journal of Biological Chemistry, vol. 271, no. 52, pp. 33157–33160, 1996.
View at: Publisher Site | Google Scholar
K. N. M. Khan, C. M. Venturini, and R. T. Bunch et al., “Interspecies differences in renal localization of cyclooxygenase isoforms: implications in nonsteroidal antiinflammatory drug-related nephrotoxicity,” Toxicologic Pathology, vol. 26, no. 5, pp. 612–620, 1998.
View at: Google Scholar
R. S. Sellers, P. B. Senese, and K. N. M. Khan, “Interspecies differences in the nephrotoxic response to cyclooxygenase inhibition,” Drug and Chemical Toxicology, vol. 27, no. 2, pp. 111–122, 2004.
View at: Publisher Site | Google Scholar
V. Câmpean, F. Theilg, A. Paliege, M. Breyer, and S. Bachmann, “Key enzymes for renal prostaglandin synthesis: site-specific expression in rodent kidney (rat, mouse),” American Journal of Physiology—Renal Physiology, vol. 285, no. 1, pp. F19–F32, 2003.
View at: Google Scholar
W. L. Smith and T. G. Bell, “Immunohistochemical localization of the prostaglandin-forming cyclooxygenase in renal cortex,” American Journal of Physiology—Renal Physiology, vol. 235, no. 5, pp. F451–F457, 1978.
View at: Google Scholar
M. G. Currie and P. Needleman, “Renal arachidonic acid metabolism,” Annual Review of Physiology, vol. 46, pp. 327–341, 1984.
View at: Publisher Site | Google Scholar
N. Kawada, G. Solis, and N. Ivey et al., “Cyclooxygenase-1-deficient mice have high sleep-to-wake blood pressure ratios and renal vasoconstriction,” Hypertension, vol. 45, no. 6, pp. 1131–1138, 2005.
View at: Publisher Site | Google Scholar
T. Okumura, I. Hayashi, and T. Ikezawa et al., “Cyclooxygenase-2 inhibitors attenuate increased blood pressure in renovascular hypertensive models, but not in deoxycorticosterone-salt hypertension,” Hypertension Research, vol. 25, no. 6, pp. 927–938, 2002.
View at: Publisher Site | Google Scholar
J. M. Gross, J. E. Dwyer, and F. G. Knox, “Natriuretic response to increased pressure is preserved with COX-2 inhibitors,” Hypertension, vol. 34, no. 5, pp. 1163–1167, 1999.
View at: Google Scholar
R. I. Clyman, P. Hardy, and N. Waleh et al., “Cyclooxygenase-2 plays a significant role in regulating the tone of the fetal lamb ductus arteriosus,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 276, no. 3, pp. R913–R921, 1999.
View at: Google Scholar
A.-M. Guerguerian, P. Hardy, and M. Bhattacharya et al., “Expression of cyclooxygenases in ductus arteriosus of fetal and newborn pigs,” American Journal of Obstetrics and Gynecology, vol. 179, no. 6, pp. 1618–1626, 1998.
View at: Publisher Site | Google Scholar
A. Koki, K. N. M. Khan, and B. M. Woerner et al., “Cyclooxygenase-2 in human pathological disease,” Advances in Experimental Medicine and Biology, vol. 507, pp. 177–184, 2002.
View at: Google Scholar
K. M. Stanfield, R. R. Bell, A. R. Lisowski, M. L. English, S. S. Saldeen, and K. N. M. Khan, “Expression of cyclooxygenase-2 in embryonic and fetal tissues during organogenesis and late pregnancy,” Birth Defects Research—Part A: Clinical and Molecular Teratology, vol. 67, no. 1, pp. 54–58, 2003.
View at: Publisher Site | Google Scholar
K. M. Stanfield, K. N. M. Khan, and M. R. Gralinski, “Localization of cyclooxygenase isozymes in cardiovascular tissues of dogs treated with naproxen,” Veterinary Immunology and Immunopathology, vol. 80, no. 3-4, pp. 309–314, 2001.
View at: Publisher Site | Google Scholar
S. Hastürk, B. Kemp, S. K. Kalapurakal, J. M. Kurie, W. K. Hong, and J. S. Lee, “Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma,” Cancer, vol. 94, no. 4, pp. 1023–1031, 2002.
View at: Publisher Site | Google Scholar
L. Ermert, M. Ermert, and M. Goppelt-Struebe et al., “Cyclooxygenase isoenzyme localization and mRNA expression in rat lungs,” American Journal of Respiratory Cell and Molecular Biology, vol. 18, no. 4, pp. 479–488, 1998.
View at: Google Scholar
M. Murakami, K. Nakashima, and D. Kamei et al., “Cellular prostaglandin $E_{2}$ production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2,” Journal of Biological Chemistry, vol. 278, no. 39, pp. 37937–37947, 2003.
View at: Publisher Site | Google Scholar
Y. Guan, Y. Zhang, and A. Schneider et al., “Urogenital distribution of a mouse membrane-associated prostaglandin $E_{2}$ synthase,” American Journal of Physiology—Renal Physiology, vol. 281, no. 6, pp. F1173–F1177, 2001.
View at: Google Scholar
G. Giannico, M. Mendez, and M. C. LaPointe, “Regulation of the membrane-localized prostaglandin E synthases mPGES-1 and mPGES-2 in cardiac myocytes and fibroblasts,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 288, no. 1, pp. H165–H174, 2005.
View at: Publisher Site | Google Scholar
J. E. Dinchuk, B. D. Car, and R. J. Focht et al., “Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II,” Nature, vol. 378, no. 6555, pp. 406–409, 1995.
View at: Publisher Site | Google Scholar
S. G. Morham, R. Langenbach, and C. D. Loftin et al., “Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse,” Cell, vol. 83, no. 3, pp. 473–482, 1995.
View at: Publisher Site | Google Scholar
J. Schnermann, “Cyclooxygenase-2 and macula densa control of renin secretion,” Nephrology Dialysis Transplantation, vol. 16, no. 9, pp. 1735–1738, 2001.
View at: Publisher Site | Google Scholar
E. K. Jackson, J. A. Oates, and R. A. Branch, “Indomethacin decreases arterial blood pressure and plasma renin activity in rats with aortic ligation,” Circulation Research, vol. 49, no. 1, pp. 180–185, 1981.
View at: Google Scholar
J.-L. Wang, H.-F. Cheng, and R. C. Harris, “Cyclooxygenase-2 inhibition decreases renin content and lowers blood pressure in a model of renovascular hypertension,” Hypertension, vol. 34, no. 1, pp. 96–101, 1999.
View at: Google Scholar
T. Yang, Y. Endo, Y. G. Huang, A. Smart, J. P. Briggs, and J. Schnermann, “Renin expression in COX-2-knockout mice on normal or low-salt diets,” American Journal of Physiology—Renal Physiology, vol. 279, no. 5, pp. F819–F825, 2000.
View at: Google Scholar
H. Takizawa, “Airway epithelial cells as regulators of airway inflammation (review),” International Journal of Molecular Medicine, vol. 1, no. 2, pp. 367–378, 1998.
View at: Google Scholar
V. J. Dzau, G. H. Gibbons, and R. E. Pratt, “Molecular mechanisms of vascular renin-angiotensin system in myointimal hyperplasia,” Hypertension, vol. 18, no. 4, supplement 2, pp. 100–105, 1991.
View at: Google Scholar
M. D. Breyer and R. C. Harris, “Cyclooxygenase 2 and the kidney,” Current Opinion in Nephrology & Hypertension, vol. 10, no. 1, pp. 89–98, 2001.
View at: Publisher Site | Google Scholar
A. V. Sampey, S. Monrad, and L. J. Crofford, “Microsomal prostaglandin E synthase-1: the inducible synthase for prostaglandin $E_{2}$ ,” Arthritis Research and Therapy, vol. 7, no. 3, pp. 114–117, 2005.
View at: Publisher Site | Google Scholar
M. Kömhoff, S. C. Reinalter, H. J. Gröne, and H. W. Seyberth, “Induction of microsomal prostaglandin $E_{2}$ synthase in the macula densa in children with hypokalemic salt-losing tubulopathies,” Pediatric Research, vol. 55, no. 2, pp. 261–266, 2004.
View at: Google Scholar

Copyright

Copyright © 2007 Zaher A. Radi and Robert Ostroski. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation Order printed copies

Views

320

Downloads

1103

Citations